HLA-G and lymphoma: Lymphoma-specific VTE risk factors (e.g., LDH, β2-microglobulin) differ substantially from solid tumors (Antic et al., 2016; Lim et al., 2016; Dharmavaram et al., 2020), explaining the poor performance of pan-cancer models.